Clinical Trials Browser

Phase 2 × Bone Marrow Failure Disorders × Emapalumab × Clear all

NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Phase 2 Recruiting

Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic